A better method of follow-up could help prevent patients with hepatitis C virus (HCV) infections from developing more severe outcomes that lead to other diseases. A team, led…
[mc4wp_form id="449"]
New research may give clinicians a better understanding of the unmet needs of biologically-naïve patients with inflammatory bowel disease (IBD). A team, led by Romina di Giuseppe, Kompetenznetz…
A regimen of direct-acting antiviral (DAA) treatments is safe and efficacious against hepatitis C virus (HCV) infections following liver transplantation. A team, led by Eric Kauffman-Ortega, MD, Hepatology…
The risk of endoscopic extension has established correlations with the clinical features of limited ulcerative colitis (UC), including early age of onset. Approximately 30% of patients with limited…
New research shows a combination treatment regimen that includes voclosporin results in clinical benefits for lupus nephritis patients. A team, led by Brad H. Rovin, MD, Department of…
New research shows only screening for hepatitis C virus (HCV) by risk in pregnant women results in a large percentage of missed diagnoses. A team, led by Elisa…
National estimates of clostridium difficile infection (CDI) infection hospitalizations by demographics and patient comorbidities are considered insufficient in the US. A team, led by Dhanshree Solanki, Edward J…
Early treatment for pediatric patients with ulcerative colitis and other gastrointestinal conditions is absolutely essential, argued Marla Dubinsky, MD, of Icahn School of Medicine at Mount Sinai. In…
While surgeries are still commonly needed for Crohn’s disease patients, the advent of biologics have reduced the need for many surgeries for this patient population. A team, led…
While current testing has largely focused on ulcerative colitis, researchers believe ABX464 could also show some promise treating Crohn’s disease as well. Researchers from Abivax, recently completed a…